Achillion: Cowen & Company Healthcare Conference (Achillion) - Mar 4, 2014 - Anticipated initiation of P2 ACH-3102 + sofosbuvir combo trial in treatment naïve GT1a/1b hep C infected patients in Q2 2014
Anticipated new P2 trial • Anticipated trial initiation date • Hepatitis C Virus
|